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S H O R T  C O M M U N I C A T I O N   Education and lipid profile in the elderly 719
in the educational program represented the in‑
terventional group, while the others were in‑
cluded in the control group. The 2 groups were 
categorized as the active group (group A) and 
the control group (group B). Initially, each group 
comprised of 100 patients. However, eventu‑
ally 93 patients participated in the education‑
al program (7 patients withdrew their consent 
to participate in the training sessions). A to‑
tal of 88 patients reported for the follow ‑up 
biochemical analyses conducted 6 months af‑
ter the end of the training program, and they 
formed the A1 group (interventional group 
at 6‑month follow ‑up). The control group in‑
cluded 97 patients (3 patients withdrew from 
the study) and represented the B1 group (con‑
trol group at 6‑month follow ‑up). Follow ‑up bio‑
chemical analyses were performed in 97 patients. 
The inclusion criteria were: age 65 years and old‑
er, stable angina pectoris, pharmacologically 
treated hypertension and lipid disorders. The ex‑
clusion criteria were: unstable angina, heart fail‑
ure, stroke, and diabetes. The training was con‑
ducted upon dividing the active group (93 pa‑
tients) into 4 smaller subgroups. Each group par‑
ticipated in 3 educational meetings, 60 minutes 
each. The meetings took place on 3 consecutive 
days for each of the 4 groups. Every day, a differ‑
ent subject related to healthy lifestyle was dis‑
cussed. The meetings were conducted by a nurse, 
a dietician, and a physical therapist with didac‑
tic experience. Moreover, every participant re‑
ceived educational materials and could consult 
health ‑related problems via the phone. Howev‑
er, none of the participants used this form of 
contact. The aim of the educational meetings 
Introduction Cardiovascular diseases, includ‑
ing ischemic heart disease, are the most com‑
mon cause of death worldwide,1,2 and lipid dis‑
orders are the principal risk factors for cardio‑
vascular diseases. It has been shown that a 10% 
reduction of total cholesterol level decreases 
the risk of acute coronary syndrome by 25%.3 
In the NATPOL PLUS study, the prevalence of 
hypercholesterolemia was 62% in women and 
59.5% in men.4 The respective values for women 
and men in the WOBASZ study were: 64% and 
67%. In the POLSENIOR study, hypercholester‑
olemia was found in 66% of women and 56% of 
men, with the highest value (70%) observed in 
participants aged 65 to 69 years.4 Disturbingly 
high low ‑density lipoprotein cholesterol con‑
centrations (73%) were noted in a study con‑
ducted in patients after hospitalization for 6 to 
8 months in cardiac wards.5 Yet another study 
showed that only 28.1% of 83.6% of patients 
treated with statins had good hypercholester‑
olemia control.6
The aim of this study was to assess the impact 
of the educational program on lipid parameters 
in older patients.
Methods The study was carried out at the 
ANIN Specialist Cardiology Clinic of the Insti‑
tute of Cardiology in Warsaw from 2014 to 2015. 
It was approved by the local ethics committee 
(no. IK ‑NP‑0021‑34/1433/14). A total of 200 
patients treated in the clinic were included in 
the study. The patients were invited to partici‑
pate in a series of training meetings aiming to 
improve lifestyle in order to change the lipid pro‑















S H O R T  C O M M U N I C A T I O N
Educational program can favorably change 
the lipid profile in older people diagnosed 
with ischemic heart disease
Beata Dziedzic¹, Jacek Imiela¹, Zofia Sienkiewicz¹, Wiesław Fidecki²
1  Department of Social Nursing, Medical University of Warsaw, Warsaw, Poland
2  Department of Development in Nursing, Medical University of Lublin, Lublin, Poland
KARDIOLOGIA POLSKA 2019; 77 (7-8)720
compared with active group A (P = 0.022). Differenc‑
es (P = 0.023) were also observed in high ‑density li‑
poprotein cholesterol between group A1 and group 
B1. The results are presented in TABLE 1.
Various authors indicated the need for further 
educational efforts within secondary prophylax‑
is in order patients to prevent future cardiovas‑
cular events, as shown by Gołuchowska et al.10 
In Poland, inpatient stationary cardiac rehabili‑
tation programs are the most common, but out‑
patient programs are rare.11 The study showed 
that effective outpatient education is feasible 
with the use of an innovative educational pro‑
gram. Rushford et al12 demonstrated in patients 
hospitalized after acute coronary events that 
there is a need for further prevention in outpa‑
tient clinics. This conclusion has been supported 
by Jankowski et al,13 who noticed that the great‑
est improvement resulted from education con‑
ducted by primary care physicians. There are 
a number of health ‑oriented educational mod‑
els worth attention. CHANGE (Care of Health 
Advertising New Goals for Elderly People) and 
EUROCATION  projects have improved risk fac‑
tor control.14,15
The  designed and implemented author‑
‑constructed outpatient educational program 
intended for elderly patients improved some 
lipid parameters in the investigated population.
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was to discuss risk factors of ischemic heart dis‑
ease, focusing especially on healthy eating hab‑
its and regular and safe physical activity. Venous 
blood cholesterol levels were measured in all 
the patients, from both the active and control 
groups at baseline and follow ‑up visit. The pa‑
tients were instructed not to eat for 12 hours be‑
fore the blood testing. Blood samples were trans‑
ported to the laboratory directly after their col‑
lection. Furthermore, data on other active risk 
factors, such as physical activity, blood pressure 
values, eating habits, and body mass index, were 
also collected. The results of these studies have 
been analyzed and published.7-9 The patients 
with abnormal lipid values were advised to seek 
medical consultation and modify treatment.
Statistical analysis For sample size calculation, 
it was assumed that 60% of the patients included 
in the study would have an increased cholesterol 
level. Moreover, assuming a significance level of 
0.05, power of the test of 80%, and effect size of 
33.3% for decreasing the percentage of individ‑
uals with an elevated cholesterol level in the ac‑
tive group, it was estimated that a statistically 
significant difference could be detected with 194 
included patients, 97 in each of the groups. In 
order to assess the relationship between nom‑
inal variables and differences in the frequency 
distributions of responses between the groups, 
contingency tables were performed and the χ2 
test was used. For 2×2 tables, the Fisher exact 
test was used. Differences between continuous 
variables were tested using the t test. The calcu‑
lations were performed in IBM SPSS 23.0 (IBM 
Corporation, Armonk, New York, United States). 
A P value of less than 0.05 was considered signif‑
icant. Mean (SD) values were calculated.
Results and discussion There were no dif‑
ferences between active group A  and con‑
trol group B apart from a variable concerning 
the place of residence (P = 0.011). The study in‑
cluded 45% of women and 55% of men. The mean 
age was similar in both groups (group  A, 
69 years; group B, 70 years). Based on medi‑
cal records, it was found that 60% of the pa‑
tients in group A and 59% in group B were di‑
agnosed with hypertension, and that 46% of 
the patients in group A and 38% in group B had 
a history of myocardial infarction. In addition, 
32% of the patients from group A and 26% from 
group B declared that they were regularly using 
cholesterol ‑lowering drugs, 44% of the patients 
from group A and 30% from group B were us‑
ing anti ‑platelet medications, 46% of the pa‑
tients from group A and 43% from group B were 
regularly using hypotensive drugs, while 67% 
of the patients from group A and 73% from 
group B were treated with β ‑blockers.
After completing the training program, tri‑
glyceride levels were lower in the active group A1 







Age, mean (SD) 69 (3.77) 70 (4.00) 0.09b
Sex, n (%) Women 47 (47) 43 (43) 0.57a
Men 53 (53) 57 (57)
Place of residence, n (%) Urban areas 95 (95) 84 (84) 0.01a
Rural areas 5 (5) 16 (16)
Education, n (%) Vocational 27 (27) 22 (22) 0.32a
Secondary 44 (44) 39 (39)
Higher 29 (29) 39 (39)
Hypertension, n (%) 60 (60) 59 (59) 0.89a
Myocardial infarction, n (%) 46 (46) 38 (38) 0.25a
Drinking alcohol, n (%) 65 (65) 64 (64) 0.88a
Lifestyle, n (%) Sedentary 68 (68) 70 (70) 0.76a
Active 32 (32) 30 (30)
Weight, kg, mean (SD) 83.8 (16.6) 82.2 (16.2) 0.50b
Height, cm, mean (SD) 168.9 (8.72) 169.1 (8.79) 0.84b
Total cholesterol ≥4.5 mmol/l, mean (SD) 4.74 (1.06) 4.75 (0.81) 0.90b
Total cholesterol ≥4.5 mmol/l, n (%) 59 (59) 60 (60) 0.89a
LDL ≥2.5 mmol/l, mean (SD) 2.98 (0.9) 3.01 (0.7) 0.83b
LDL ≥2.5 mmol/l, n (%) 64 (64) 75 (75) 0.09a
HDL ≤1.2 mmol/l in women, ≤1.0 mmol/l in men, 
mean (SD)
1.34 (0.26) 1.36 (0.31) 0.57b
HDL ≤1.2 mmol/l in women, ≤1.0 mmol/l in men, n (%) 18 (18) 18 (18) 1.00a
TG ≥1.7 mmol/l, mean (SD) 1.65 (0.55) 1.63 (0.53) 0.80b






Total cholesterol ≥4.5 mmol/l, mean (SD) 4.43 (0.78) 4.53 (0.72) 0.38b
Total cholesterol ≥4.5 mmol/l, n (%) 43 (48.9) 52 (53.6) 0.52a
LDL ≥2.5 mmol/l, mean (SD) 2.72 (0.73) 2.82 (0.64) 0.36b
LDL ≥2.5 mmol/l, n (%) 53 (60.2) 64 (65.9) 0.51a
HDL ≤1.2 mmol/l in women, ≤1.0 mmol/l in men, 
mean (SD)
1.41 (0.27) 1.43 (0.35) 0.67b
HDL ≤1.2 mmol/l in women, ≤1.0 mmol/l in men, n (%) 7 (8.0) 19 (19.6) 0.02a
TG ≥1.7 mmol/l, mean (SD) 1.49 (0.45) 1.50 (0.46) 0.90b
TG ≥1.7 mmol/l, n (%) 27 (30.7) 27 (27.8) 0.67a
Parameters after intervention Compared groups χ2 test P value
Total cholesterol A vs A1 1.94 0.16a
B vs B1 0.82 0.37a
LDL cholesterol A vs A1 0.28 0.59a
B vs B1 1.93 0.17a
HDL cholesterol A vs A1 3.44 0.06a
B vs B1 0.08 0.78a
TG A vs A1 5.22 0.02a
B vs B1 2.76 0.10a
a   χ2 test; b t test
Abbreviations: HDL, high ‑density lipoprotein; LDL, low ‑density lipoprotein; TG, triglycerides
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